Qube Research & Technologies (QRT)
FLGT icon

Qube Research & Technologies (QRT)’s Fulgent Genetics FLGT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-286,511
Closed -$7.53M – 3707
2025
Q4 		$7.53M Buy
286,511
+201,452
+237% +$5.23M 0.01% 1517
2025
Q3 		$1.92M Buy
85,059
+29,264
+52% +$603K ﹤0.01% 2253
2025
Q2 		$1.11M Sell
55,795
-66,112
-54% -$1.29M ﹤0.01% 2419
2025
Q1 		$2.06M Buy
+121,907
New +$2.08M ﹤0.01% 1943
2023
Q1 		– Sell
-16,022
Closed -$477K – 2691
2022
Q4 		$477K Sell
16,022
-4,044
-20% -$145K ﹤0.01% 1486
2022
Q3 		$765K Buy
20,066
+2,772
+16% +$139K ﹤0.01% 1303
2022
Q2 		$943K Buy
+17,294
New +$950K 0.01% 1129
2020
Q2 		– Sell
-16,478
Closed -$177K – 1797
2020
Q1 		$177K Sell
16,478
-20,114
-55% -$280K 0.01% 894
2019
Q4 		$472K Buy
+36,592
New +$435K 0.01% 977

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FLGT Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 286,511 shares — an estimated $7.53M sold.

Qube Research & Technologies (QRT) first reported a position in FLGT in Q4 2019 and held it in 9 quarters. The position peaked at $7.53M in Q4 2025. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 286,511 Fulgent Genetics shares in Q1 2026, an estimated $7.53M.
  • Qube Research & Technologies (QRT) first reported a position in Fulgent Genetics in Q4 2019 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Fulgent Genetics position peaked at $7.53M in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.